Designing supramolecular therapies to cross the blood-brain barrier
A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for this novel approach to treating neurological disorders.
A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for this novel approach to treating neurological disorders. This story matters for Science & Discovery readers tracking mech. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. MechNews.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily mech signal